Skip to main content

Smart Insulin Pens Market Size to Surpass USD 1,514.6 Million by 2030, exhibiting a CAGR of 10.4%

According to the report by Fortune Business Insights, the global Smart Insulin Pens Market size is projected to reach USD 1,514.6 Million by 2030, at a CAGR of 10.4% during the forecast period, 2023-2030

Smart Insulin Pens Market

Smart Insulin Pens Market Forecast 2023-2030
Smart Insulin Pens Market Forecast 2023-2030

Pune, India, Nov. 20, 2023 (GLOBE NEWSWIRE) — The smart insulin pens market is expected to expand from USD 755.4 million in 2023 to USD 1,514.6 million by 2030, exhibiting a CAGR of 10.4% over the study period. Smart insulin pens help track the amount of insulin injected and time, enabling users to input carbohydrate intake, glucose levels, and exercise regimens.

Fortune Business Insights™ provides this information in its research report, titled “Smart Insulin Pens Market, 2023-2030”.

 

Request a Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/smart-insulin-pens-market-108566


Key Industry Development:

  • September 2022 – Medtronic plc launched its Smart MDI system in Europe, which includes a smart Continuous Glucose Monitor (CGM) and InPen system, a smart insulin pen and Guardian 4 system.

Key Takeaways:

  • The market expansion can be credited to the rising awareness among people diagnosed with diabetes about new technologies.
  • The increasing precision in dose calculation provided by smart insulin pens is contributing to improved clinical outcomes for diabetic patients.
  • North America dominated the global market and generated a revenue of USD 283.3 million in 2022.
  • The retail & online pharmacies segment is anticipated to grow rapidly during the forecast period.

List of Key Market Players Profiled in the Report:

“Companies leading the global Smart Insulin Pens Market are Novo Nordisk A/S (Denmark), Medtronic (Ireland), Ypsomed AG (Switzerland), Emperra GmbH (Germany), Pendiq (Germany), Jiangsu Deflu Medical Device Co. (China), Cambridge Consultants Ltd. (U.K.), Diabnext (France)”

Report Scope & Segmentation

Report CoverageDetails
Forecast Period2023 to 2030
Forecast Period 2023 to 2030 CAGR10.4%
2030 Value ProjectionUSD 1,514.6 Million
Base Year2022
Market Size in 2023USD 755.4 million
Historical Data2019 to 2021
No. of Pages125
Segments coveredBy Connectivity, Indication, Distribution Channel and Region


Browse Complete Report Details: https://www.fortunebusinessinsights.com/smart-insulin-pens-market-108566


Segmentation:

More Flexibility in Bluetooth to Foster Segment Growth

In terms of connectivity, the market is segmented into Bluetooth and Near Field Communication (NFC). The Bluetooth segment accounted for a significant market share in 2022. The technology allows more flexibility in usage due to the longer range of connectivity, up to around 100 meters. This factor is bolstering the Bluetooth segment growth.

Rising Number of Insulin-dependent Patients to Impel Type 1 Diabetes Segment Growth

By indication, the market is divided into type 1 diabetes and type 2 diabetes. The type 1 diabetes segment held a substantial market share in 2022, owing to the growing number of insulin-dependent patients globally.

Availability of Advanced Procurement Facilities to Boost Hospital Pharmacies Segment Growth

In terms of distribution channel, the market is categorized into retail & online pharmacies and hospital pharmacies. The hospital pharmacies segment is expected to witness a significant market share during the forecast period. The availability of the product and advanced procurement facilities in hospital pharmacies is driving the segment growth.

Based on region, the market is divided into Europe, North America, Asia Pacific, and the rest of the world.

By Connectivity

  • BluetoothNear
  • Field Communication (NFC)

By Indication

  • Type 1 Diabetes
  • Type 2 Diabetes

By Distribution Channel

  • Hospital Pharmacies
  • Retail & Online Pharmacies

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World


Quick Buy – Smart Insulin Pens Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/108566


Drivers and Restraints:

Surging Emphasis on Digital Diabetes Ecosystem to Escalate Market Growth

One of the major factors impelling the smart insulin pens market growth is an increase in the focus on the digital diabetes ecosystem. Medical care is witnessing the mass development of new tools due to the growing adoption of the Internet of Medical Things (IoMT) and the surge in digital health solutions.

Despite such an expanding scope for the adoption of the product, the limited availability of smart insulin pens in emerging economies and the steep cost may impede market growth.

Regional Insights:

North America Dominated Due to Surging Uptake of Connected Insulin Pens

North America smart insulin pens market accounted for the largest share in 2022. The adoption of connected insulin pens is increasing in the region. This factor is propelling regional growth.

Europe held the second largest smart insulin pens market share in 2022, owing to the surging incidence of diabetes.

Competitive Landscape:

Notable Companies Focus on Product Innovations to Broaden Their Offerings

Major market players are forging partnerships, deploying mergers and acquisition strategies, joint ventures, and others. Product innovation strategies are also being implemented by leading companies to increase their product portfolio.

FAQ’s

How big is the Smart Insulin Pens Market? 

Smart Insulin Pens Market size was USD 694.2 million in 2022. It is expected to reach USD 1,514.6 million by 2030.

How fast is the Smart Insulin Pens Market growing?

The Smart Insulin Pens Market will exhibit a CAGR of 10.4% during the forecast period, 2023-2030


Speak to Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/smart-insulin-pens-market-108566


Related Reports:

Digital Diabetes Management Market Growth, Industry Analysis, Demand and Forecast

Diabetes Treatment Devices Market Size, Share, Opportunities & Analysis

Insulin Pens Market Overview, Industry Share and Forecast

Insulin Pump Market Demand, Size, Share and Forecast

About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies interspersed with relevant data. 

Contact Us:
Fortune Business Insights Pvt. Ltd.
9th Floor, Icon Tower, Baner – Mahalunge Road,
Baner, Pune-411045,
Maharashtra, India.

Phone:
U.S.:+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.